Effects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exercise

Lowe, A; Kitchen, S; Jennings, I; Kitchen, DP; Woods, TAL; Walker, ID

Lowe, A (corresponding author), UK NEQAS BC, 3rd Floor,Pegasus House,436a Glossop Rd, Sheffield S10 2QD, S Yorkshire, England.

HAEMOPHILIA, 2020; 26 (6): 1087

Abstract

Introduction Emicizumab (Hemlibra: Roche Switzerland) is a, humanized, bi-specific monoclonal modified immunoglobulin G4 (IgG4) which binds human FX, ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索